These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12403670)

  • 1. Oral everolimus inhibits in-stent neointimal growth.
    Farb A; John M; Acampado E; Kolodgie FD; Prescott MF; Virmani R
    Circulation; 2002 Oct; 106(18):2379-84. PubMed ID: 12403670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Hellinga D; Seabron R; Kolodgie F; Virmani R
    Cardiovasc Revasc Med; 2006; 7(3):179-84. PubMed ID: 16945826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks.
    Bünger CM; Grabow N; Kröger C; Lorenzen B; Hauenstein K; Goosmann M; Schmitz KP; Kreutzer HJ; Lootz D; Ince H; Nienaber CA; Klar E; Schareck W; Sternberg K
    J Endovasc Ther; 2006 Oct; 13(5):630-9. PubMed ID: 17042669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.
    Danenberg HD; Golomb G; Groothuis A; Gao J; Epstein H; Swaminathan RV; Seifert P; Edelman ER
    Circulation; 2003 Dec; 108(22):2798-804. PubMed ID: 14610008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
    Zhao HQ; Nikanorov A; Virmani R; Schwartz LB
    J Vasc Surg; 2012 Dec; 56(6):1680-8. PubMed ID: 22841285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
    J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries.
    Torii S; Nakazawa G; Ijichi T; Yoshikawa A; Ohno Y; Ikari Y
    Cardiovasc Interv Ther; 2018 Jan; 33(1):55-61. PubMed ID: 27822890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization.
    Tanous D; Bräsen JH; Choy K; Wu BJ; Kathir K; Lau A; Celermajer DS; Stocker R
    Atherosclerosis; 2006 Dec; 189(2):342-9. PubMed ID: 16529750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent.
    Klugherz BD; Llanos G; Lieuallen W; Kopia GA; Papandreou G; Narayan P; Sasseen B; Adelman SJ; Falotico R; Wilensky RL
    Coron Artery Dis; 2002 May; 13(3):183-8. PubMed ID: 12131023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral everolimus inhibits neointimal proliferation in prosthetic pulmonary valved stents in pigs.
    Kuehne T; Pietzner K; Lehmkuhl HB; Gelernter D; Peters B; Krueger JJ; Meinus C; Klimes K; Brinkert F; Ewert P; Berger F
    J Heart Valve Dis; 2008 Jul; 17(4):465-72. PubMed ID: 18751477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-eluting stents improve vascular response in a diabetic animal model.
    Habib A; Karmali V; John MC; Polavarapu R; Nakazawa G; Pachura K; Davis T; Kolodgie FD; Virmani R; Finn AV
    Circ Cardiovasc Interv; 2014 Aug; 7(4):526-32. PubMed ID: 24915972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin impairs endothelialization after placement of newer generation drug eluting stents.
    Habib A; Karmali V; Polavarapu R; Akahori H; Pachura K; Finn AV
    Atherosclerosis; 2013 Aug; 229(2):385-7. PubMed ID: 23880192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.